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Management
A 43-year old female (gravida 3, para 1) presented to an outside
hospital with pelvic pain and vaginal bleeding in December 2012, for
which she was admitted to the emergency room; following a physical
examination and CT scan of the pelvis, a 20 × 10 × 15 cm pelvic mass
was identiﬁed. The lesion was compressing the rectum, bladder and
left ureter, which caused severe, ipsilateral hydronephrosis. The
patient's medical history was signiﬁcant for a supracervical hysterecto-Introduction
Uterine leiomyosarcoma is an aggressive malignancy associated
with an unfavorable clinical outcome (Coard and Fletcher, 2002).
Intravenous leiomyosarcomatosis with cardiac extension is an ex-
tremely uncommon phenomenon wherein malignant smooth mus-
cle cells of myometrial provenance metastasize to the heart (Ma
et al., 2007). Since cardiac intravenous leiomyosarcomatosis was ini-
tially reported (Moorjani et al., 2005; Montemezzi, 1966), only scant
cases have been documented in the literature (Coard and Fletcher,
2002; Ma et al., 2007; Moorjani et al., 2005).
Typically, intravenous leiomyosarcomatosis, similar to intravenous
leiomyomatosis (IVL), is conﬁned to the pelvis; but when intravenous
leiomyosarcomatosis is exposed to cardiac venous blood ﬂow, the infe-
rior vena cava, or right-sided atrial, ventricular or pulmonary arterial
blood ﬂow, inﬁltration potentially occurs (Coard and Fletcher, 2002).
In cases of intra-cardiac leiomyosarcomatosis, patients can present
with a murmur, syncope or spontaneous cardiac death (Ma et al.,
2007; McDonald et al., 2007; Ahmed et al., 2004). Unfortunately, since
intravenous leiomyosarcomatosis is quite rare and the clinical index of
suspicion is extensive, an expeditious diagnosis may be confounded.search Foundation.
ciates, 351 Hospital Road, Suite
57.
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c. Open access under CC BY-NC-ND license.my in 2008 to address uterine ﬁbroids; her most recent Pap smear and
pelvic exam, both of which were negative for malignancy, coincided
with the aforesaid hysterectomy.
In January 2013, the patient underwent an exploratory laparotomy,
biopsy and lysis of adhesions,which revealed a 10 × 8 cmnecrotic, vag-
inalmasswith a 5 × 5 cmpedicle at the vaginal apex. Subsequently, the
mass and lysis of adhesions were biopsied. Abdominally, she had a
10 × 15 cm solid mass posterior to the bladder, normal-appearing
right tube and ovary; there was a large amount of omental adhesions,
which were lysed. The patient received 2 units of blood prior to the
surgery and received an additional 2 L of blood intra-operatively; ulti-
mately, she tolerated the procedure well.
Pathology of the pelvic mass revealed a hypercellular lesion without
signiﬁcant mitotic activity, atypia or necrosis, consistent with a cellular
leiomyoma. The vaginal mass was composed predominantly of non-
viable/necrotic tissue and only focal viable atypical tissue was available
for evaluation (Fig. 1a); albeit suspicious for malignancy, given the
scant nature of the atypical focus (Fig. 1b), a deﬁnitive diagnosis of ma-
lignancy could not be rendered at that time. Consequently, in lieu of a re-
biopsy, the oncology team opted for complete removal of the disease.
The patient continued to suffer from intractable vaginal bleeding
and thus, she underwent an abdominal aortogram, selective bilateral in-
ternal iliac arteriography and embolization of the pelvicmass in January
2013. Selective left hypogastric branch vessels demonstrated signiﬁcant
tumor vascularity; they were catheterized and then embolized, which
effectuated a substantial reduction of tumor ﬂow. Moreover, super se-
lective injection of one branch demonstrated active arterial extravasa-
tion; this was successfully resolved following coil embolization.
A follow-up CT of the chest, abdomen and pelvis revealed a large
thrombus in the inferior vena cava (IVC) and left iliac veins, which
extended into the right atrium (Fig. 2); there was also evidence of en-
hancement, indicative of tumor thrombus or benign metastasizing
leiomyomatosis. In consideration of the lesion's presence in the right
Fig. 1. a–b. Only focal, viable atypical spindle cells were identiﬁed, showing nuclear atypia
and possible increasedmitotic activity (H&E, 200×magniﬁcation) (a). Highpower viewof
cellular spindle cell proliferation showing the lack of malignant features consistent with a
cellular leiomyoma (H&E, 200× magniﬁcation) (b).
Fig. 2. A coronal CT image of tumor thrombus extending from the pelvis through the infe-
rior vena cava into the right atrium.
Fig. 3. Transthoracic echocardiogram exhibiting a mass (arrow) extending from the supe-
rior vena cava (SVC) into the right atrium (RA); the left atrium (LA), right ventricle (RV)
and left ventricle (LV) are also visualized.
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mended and an ensuing transthoracic echocardiogram was performed
(Fig. 3).
Interestingly, the patient's medical history was negative for any car-
diac or thoracic symptomatology. She also denied any speciﬁc knowl-
edge of having a myocardial infarction, dysrhythmias, palpitations, or
cardiac murmurs. Nonetheless, the patient reported increased dyspnea
in the fewmonths preceding her hospitalization; her sitting blood pres-
sure was 132/92 mm Hg and pulse rate was 133 beats/min.
In February 2013, the patient was admitted to the emergency room
due to asthenia, vertigo and a urinary tract infection; she also reported
moderate bleeding. The patient was febrile at 102 °F; her hematocrit
was 29% and creatinine was 1.2 mg/dL. The patient was administered
antibiotic therapy and transfused with 2 units of packed red blood
cells to ameliorate her symptoms.
Intra-cardiac leiomyosarcomatosis is an extremely complex and
precarious condition and thus, the patient's management necessitated
a multidisciplinary, formulated approach; this involved substantive
pre-operative discussion among the cardiovascular, vascular, and gyne-
cologic oncology surgeons. Since signiﬁcant patient blood loss was
anticipated, a comprehensive transfusion protocol was thereby institut-
ed. Moreover, the operating roomwas reserved for the entire day to ac-
commodate this multifaceted surgical procedure.Initially, the patient underwent cardiovascular surgery, comprising a
sternotomy via a combination of central and peripheral cannulation in
the right common femoral vein, extending up to the common iliac artery.
The heart was arrested; cardioplegia was administered at 30-minute
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headwas packed in ice. Simultaneously, a right atriotomywas performed
with removal of the right ventricular and atrial components of the mass;
there was no tumor identiﬁed in the ventricle and/or coronary sinus.
The tumor was removed en bloc approximately 2 cm into the IVC;
however, the mass was friable and had to be removed in discrete
sections (Fig. 4), indicative of a malignant process. A Foley catheter
was used as a Fogarty arterial embolectomy catheter into the IVC, of
which successive passes were negative for evidence of tumor or throm-
bus. The right atrium was closed with 5-0 Prolene suture in a running
technique; the IVC was closed and cardiopulmonary bypass was
reinstituted; the aortic crossclamp was removed, allowing for cardiac
resuscitation.
Vascular surgery consultation was then indicated; thereafter, a vena
cava thrombectomy, right common iliac tumor thrombectomy and left
common and external iliac tumor thrombectomy were planned. Total
circulatory arrest was necessary to extract the tumor from the patient's
ventricle and IVC. The neoplasm's removal from the iliac system
occurred in 2 stages. During total circulatory arrest, the heart and vena
cavawere opened. The tumorwas extracted; similar to the cardiovascu-
lar surgery, the mass was incohesive and thus, removed in distinct seg-
ments; estimated blood loss was approximately 4 L.
The ﬁnal operative component encompassed gynecologic oncology
surgery. Initially, the retroperitoneum on the right side was entered.
Once the vagina was identiﬁed, the posterior region was divided, en-
tered and the rectovaginal space was developed. An ovarian cyst was
visualized and subsequently removed using blunt dissection; the blad-
der and ureters were both mobilized. Accordingly, the pelvic mass was
completely mobilized.
Once the lesion was completely unencumbered, the neoplasm was
extracted from the pelvis. Hemostasis was appreciated although there
was large volume blood loss (10 L), necessitating amassive transfusion.
The patient received 34 units of packed red blood cells, 30 units of
cryoprecipitate, 8 units of fresh frozen plaza, 7 units of platelets and
one dose of Recombinant Factor VIIa.When the procedurewas conclud-
ed, she was taken to the Cardiovascular Intensive Care Unit in stable
condition.
Despite the initial pre-operative pathology results (i.e., a cellular
leiomyoma), additional evaluation of the patient's gynecologic and vas-
cular specimens revealed a high grade leiomyosarcoma of uterine origin.
At the conclusion of surgery, the patient did well; she did not suffer from
any signiﬁcant complications and fulﬁlled all appropriate recovery
criteria prior to discharge, which occurred on postoperative day 18.
Consequently, she began six cycles of gemcitabine (1000 mg/m2) and
docetaxel (75 mg/m2) chemotherapy.
Discussion
Intravenous leiomyosarcomatosis potentially represents a malig-
nant subtype of IVL (McDonald et al., 2007). This more aggressive
condition is extremely uncommon and can portend inauspicious
health consequences. In particular, when there is cardiac extension,
the patient is at signiﬁcant risk for a thrombotic and neoplasticinduced pulmonary embolic event (McDonald et al., 2007; Ahmed
et al., 2004; Burns et al., 1979).
One proposed theory regarding the pathogenesis of intravenous
leiomyomatosis suggests that the intima of myometrial sinuses is
invaded by leiomyomatosis cells of uterine myometrial provenance
(Sizenfrey, 1911). Alternatively, with intravenous leiomyosarcomatosis,
the malignancy consists of proliferating smoothmuscle cells originating
from the venous wall of the uterine or pelvic veins (Norris and Parmley,
1975). In the current study, the disease presumably migrated from the
internal iliac veins, proximal to the uterus. Interestingly, our patient
was initially treated via supracervical hysterectomy; one could conjec-
ture that the residual cervical tissue contributed to thedisease's ultimate
efﬂorescence, since unanticipated malignancies have been reported in
conjunction with this surgical procedure (Theben et al., 2013).
Successful therapy relies on advanced preparation comprising
multi-disciplinary collaboration (Moorjani et al., 2005). Collectively,
the surgical divisions developed a procedure to effectively manage the
disease; this involved reserving the operative room for the entire day
to accommodate the protracted surgical period and preparing a transfu-
sion protocol in anticipation of the signiﬁcant blood loss. When manag-
ing intravenous leiomyosarcomatosis, we elected to emphasize loco-
regional treatment comprising surgery and adjuvant therapy (Coard
and Fletcher, 2002; Ma et al., 2007; Moorjani et al., 2005); albeit specu-
lative, anti-estrogens may also confer some clinical beneﬁt (Theben
et al., 2013). Furthermore, since this disease is associated with signiﬁ-
cant morbidity and patients have a propensity for developing recurrent
disease, active patient counseling and surveillance are necessary.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gynor.2013.07.001.
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